HeartSine Technologies, a spin-out from the University of Ulster, became a world leader in personal and public access defibrillators, advances the deployment of lifesaving defibrillation therapy for the treatment of sudden cardiac arrest in non-traditional areas of care. Heartsine was acquired by Physio Control and subsequently by Stryker Inc. NYSE:SYK

ACT was the lead investor in Heartsine following the Series A investment with co-investors, Enterprise Equity, Clarendon Fund Managers and Viridian Growth Fund.